MYOZYME Trademark

Trademark Overview

On Thursday, June 6, 2002, a trademark application was filed for MYOZYME with the United States Patent and Trademark Office. The USPTO has given the MYOZYME trademark a serial number of 78133703. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 17, 2024. This trademark is owned by Genzyme Corporation. The MYOZYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of lysosomal storage diseases
myozyme

General Information

Serial Number78133703
Word MarkMYOZYME
Filing DateThursday, June 6, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 17, 2024
Registration Number2780777
Registration DateTuesday, November 4, 2003
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 3, 2002

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of lysosomal storage diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 17, 2024
Primary Code005
First Use Anywhere DateThursday, July 10, 2003
First Use In Commerce DateThursday, July 10, 2003

Trademark Owner History

Party NameGenzyme Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701

Trademark Events

Event DateEvent Description
Monday, July 21, 2003TEAS STATEMENT OF USE RECEIVED
Monday, July 21, 2003STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 26, 2002ASSIGNED TO EXAMINER
Saturday, September 28, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2002NOTICE OF PUBLICATION
Tuesday, December 3, 2002PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 21, 2003USE AMENDMENT FILED
Tuesday, October 29, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, August 28, 2003CASE FILE IN TICRS
Friday, August 29, 2003ASSIGNED TO EXAMINER
Wednesday, September 3, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 4, 2003REGISTERED-PRINCIPAL REGISTER
Monday, September 19, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 10, 2008TEAS SECTION 8 & 15 RECEIVED
Friday, November 14, 2008ASSIGNED TO PARALEGAL
Saturday, December 20, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 29, 2013TEAS SECTION 8 & 9 RECEIVED
Saturday, November 2, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 2, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, November 2, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, November 2, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 12, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 12, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, November 4, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 17, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

myozyme diseases storage lysosomal treatment pharmaceuticals